MOLECULAR MECHANISMS AND COMBINATION STRATEGIES WITH PI3K AND BTK INHIBITORS TO OVERCOME INTRINSIC AND ACQUIRED RESISTANCE IN PRECLINICAL MODELS OF ABC‐DLBCL

J. Paul, M. Soujon,A.M. Wengner, S. Zitzmann‐Kolbe, A. Sturz, K. Haike, H.M. Koh,S. Tan, M. Lange,D. Mumberg,S. Lim,K. Ziegelbauer,N. Liu

Hematological Oncology（2017）

Cited 1|Views22

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined